Kinetic and computational molecular docking simulation study of novel kojic acid derivatives as anti-tyrosinase and antioxidant agents

The novel kojic acid derivatives KAD1 and KAD2 have been demonstrated that they exhibited potent anti-melanogenesis activity in our previous report. In this study, we further study the inhibitory mechanism on mushroom tyrosinase. The inhibitory types of both KADs on diphenolase were classified as mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan-Mei Chen (Author), Chen Li (Author), Wen-Jing Zhang (Author), Yan Shi (Author), Zi-Jie Wen (Author), Qing-Xi Chen (Author), Qin Wang (Author)
Format: Book
Published: Taylor & Francis Group, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0e21e9d27f4744fc848fb461db87fc9f
042 |a dc 
100 1 0 |a Yan-Mei Chen  |e author 
700 1 0 |a Chen Li  |e author 
700 1 0 |a Wen-Jing Zhang  |e author 
700 1 0 |a Yan Shi  |e author 
700 1 0 |a Zi-Jie Wen  |e author 
700 1 0 |a Qing-Xi Chen  |e author 
700 1 0 |a Qin Wang  |e author 
245 0 0 |a Kinetic and computational molecular docking simulation study of novel kojic acid derivatives as anti-tyrosinase and antioxidant agents 
260 |b Taylor & Francis Group,   |c 2019-01-01T00:00:00Z. 
500 |a 1475-6366 
500 |a 1475-6374 
500 |a 10.1080/14756366.2019.1609467 
520 |a The novel kojic acid derivatives KAD1 and KAD2 have been demonstrated that they exhibited potent anti-melanogenesis activity in our previous report. In this study, we further study the inhibitory mechanism on mushroom tyrosinase. The inhibitory types of both KADs on diphenolase were classified as mixed type based on the results of the kinetic model. The interaction between KADs and tyrosinase was illustrated by fluorescence quenching, molecular docking and copper chelate activity. The KADs were also evaluated with respect to their antioxidant activities by DPPH and ABTS+ assays. The results showed that KADs have more potent antioxidant activities than kojic acid. Our study could provide new ideas for the development of new anti-tyrosinase and antioxidant agents. 
546 |a EN 
690 |a kojic acid derivatives 
690 |a tyrosinase inhibition 
690 |a antioxidant 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 990-998 (2019) 
787 0 |n http://dx.doi.org/10.1080/14756366.2019.1609467 
787 0 |n https://doaj.org/toc/1475-6366 
787 0 |n https://doaj.org/toc/1475-6374 
856 4 1 |u https://doaj.org/article/0e21e9d27f4744fc848fb461db87fc9f  |z Connect to this object online.